TrumpRX: Medicare’s New Weight Loss Coke—Now in Pill Form!
In a twist messier than a TikTok diet challenge, the Trump administration is creeping towards a pharma bromance with Eli Lilly and Novo Nordisk to make weight loss drugs like Wegovy and Zepbound cheaper and Medicare-eligible. Imagine Wegovy dropping to $149/month on TrumpRX (official whitehouse-tool-for-shedding-bills) while Zepbound flexes at $299. Oh, and remember the April 2025 sabotage of Biden’s $40B idea to cover these magic needles? Yeah, now Trump’s shopping that buffet again, aiming to cover these drugs for both Medicare and possibly Medicaid users. Half of obese seniors were already halfway in before this saga even began.
Share the Story
Trump's Medicare deal lets seniors lose weight for less while confusing the internet about who really hates spending big on drugs. Meanwhile, Wegovy and Zepbound are like the overpriced avocado toast of pharmaceuticals – now 'affordable' at hundreds a month!
Medicare covering weight loss drugs finally proves the government cares about more than just Twitter polls and obscure middle names.
Drug companies dropping prices on weight loss meds after politics does the math feels like your diet: inconsistent, overpriced, but somehow still hopeful.
Source: Axios | Published: 11/4/2025 | Author: Caitlin Owens
More Articles in Health
Ed Sheeran Launches 2026 LOOP Tour, Tickets Not Looping Into Your Wallet
Congress Trades Shouting Match Over ICE Shooting Like A Twin Cities Soap Opera
Federal Agents Play Hide-And-Seek With Guns, Accidentally Shoot People
Kennedy’s Protein-Heavy Food Pyramid: Eat More Meat, But Not Saturated Fat, Or Something
Parents Swap 'Because I Said So' For 'Oops, You Bought Too Much Junk'
America Celebrates Lower Gun Deaths While Puffing More Vape Clouds
Trump's Vaccine Makeover: Fewer Shots, More Trust, Same Measles Risks
Woman’s Epic Fight: Type 1 Diabetes vs. Ancient Mexican Ruins Timer
